BMS-357075
BMS-357075 is a pan-CDK inhibitor with CDK1 IC50 18 nM, CDK2 IC50 3 nM, CDK4 IC50 26 nM. BMS-357075 induces cytotoxicity in human ovarian cancer A2780 cells. BMS-357075 exhibits anticancer activity in mice against P388 murine leukemia. BMS-357075 can be used for the research of leukemia.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 350509-99-8
- 分子式: C22H31N5O2S2
- 分子量:461.64
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
[1]|
CDK1/cyclinB1 18 nM (IC50) |
CDK2/cyclinE 3 nM (IC50) |
CDK4/cyclin D 26 nM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A2780 | IC50 |
3 nM
Compound: 19
|
Cytotoxic effect on human ovarian (A2780) cancer cell line
Cytotoxic effect on human ovarian (A2780) cancer cell line
|
[PMID: 15125971] |
体外実験
BMS-357075 (compound 19) potently inhibits CDK1/cyclin B (IC50 = 18 nM), CDK2/cyclin E (IC50 = 3 nM), and CDK4/cyclin D (IC50 = 26 nM) in cell-free enzyme assays[1].
BMS-357075 potently inhibits the viability of human ovarian cancer A2780 cells with an IC50 of 3 nM[1].
BMS-357075 shows 90% protein binding in mouse serum[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 350509-99-8
-
分子量 461.64
-
分子式 C22H31N5O2S2
-
SMILES
OCC(C)(CNCC1=CN=C(NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)C=C1)C
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)